The expression of mouse VEGF-A, VEGF-C, and VEGF-D mRNAs was also higher in LNM35 tumors (Figure 2E), suggesting that tumor stromal cells are responsible for the increased expression of both angiogenic and lymphangiogenic factors. The gene discussed is VEGFD; the disease is neoplasm.